Tuesday, June 20 • 4:00pm - 5:15pm
#284: Use of Novel Trial Designs to Accelerate Decision Making: To 'P' No More

Sign up or log in to save this to your schedule and see who's attending!

Component Type: Session
Level: Intermediate
CE: CME 1.25; IACET 1.25; RN 1.25

This session will provide case studies where Bayesian statistical approaches and adaptive designs have facilitated go/no-go decisions in small proof of concept studies.

Learning Objectives

Discuss Bayesian framework for decision-making; Describe early phase scenarios for adaptive trial designs.


Jonathan Haddad, MPH


Biomarker-Guided Adaptive Trial Designs
Nusrat Rabbee, PhD

Kert Viele, PhD

avatar for Jonathan Haddad

Jonathan Haddad

Director, Clinical Statistics, GlaxoSmithKline
20 years experience building & leading Biometrics groups in biotech sector. Experience includes oncology, inflammatory diseases and dermatology.

avatar for Nusrat Rabbee

Nusrat Rabbee

Senior Statistical Fellow, Covance Inc.
Nusrat Rabbee is the Senior Statistical Fellow at Covance. She specializes in statistical methods in drug and diagnostic test development. She worked as an independent consultant, and at Veracyte and Genentech in development of bioinformatics algorithms and biomarker based drugs... Read More →

Kert Viele

Director and Senior Statistical Scientist, Berry Consultants
Kert Viele is a Director and Senior Statistical Scientist with Berry Consultants, specializing in the design of Bayesian and adaptive clinical trials. He joined Berry Consultants in 2010 after serving as a faculty member in Statistics at the University of Kentucky. He is a former... Read More →

Tuesday June 20, 2017 4:00pm - 5:15pm
S401a McCormick Place 2301 South Martin Luther King Jr. Drive, Gate 4 Chicago, IL 60616